Double bottom with RSI divergence, expect 13% upside in short term Reasons: 1. double bottom 2. RSI divergence 3. Health pharma sector showing reversal signs
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.